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Abstract
Background: A national chlamydia screening programme is currently being rolled out in the UK
and other countries. However, much of the epidemiology remains poorly understood. In this paper
we present a stochastic, individual based, dynamic sexual network model of chlamydia transmission
and its parameterisation. Mathematical models provide a theoretical framework for understanding
the key epidemiological features of chlamydia: sexual behaviour, health care seeking and
transmission dynamics.
Results: The model parameters were estimated either directly or by systematic fitting to a variety
of appropriate data sources. The fitted model was representative of sexual behaviour, chlamydia
epidemiology and health care use in England. We were able to recapture the observed age
distribution of chlamydia prevalence.
Conclusion: Estimating parameters for models of sexual behaviour and transmission of chlamydia
is complex. Most of the parameter values are highly correlated, highly variable and there is little
empirical evidence to inform estimates. We used a novel approach to estimate the rate of active
treatment seeking, by combining data sources, which improved the credibility of the model results.
The model structure is flexible and is broadly applicable to other developed world settings and
provides a practical tool for public health decision makers.
Background
Chlamydia is a very common, curable sexually transmit-
ted infection (STI) caused by the Chlamydia trachomatis
bacteria. Chlamydia prevalence in young women attend-
ing general practice in Britain was estimated to be 8.1% in
those under 20 and 5.2% in those aged 20–24 [1], and is
similar in other developed countries. Many infections are
asymptomatic, resulting in a large reservoir of undetected,
untreated infections [2]. Untreated chlamydia infection
may result in long-term sequelae in women including pel-
vic inflammatory disease (PID) and ectopic pregnancy
[3]. Detection of chlamydia has become easier with the
recent introduction of rapid, sensitive, affordable, and
non-invasive DNA tests [4]. Treatment is also straightfor-
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ward and inexpensive with doxycycline or azithromycin
[5]. Chlamydia screening therefore, has been or is being
implemented in various developed countries including
USA, Sweden, Netherlands, and UK [6-9]. However much
of the epidemiology of chlamydia remains poorly under-
stood [10] and there are many questions regarding the
long term impact of interventions, such as how much PID
is attributable to chlamydia infection and what are the
economic and health costs and benefits of chlamydia
screening? Appropriate mathematical models are required
to address these questions adequately. Models are able to
compare a variety of "what if" scenarios and inform esti-
mates of biological and epidemiological parameters
which are difficult to measure in practice e.g. transmission
rate or the proportion of symptomatic cases seeking treat-
ment.
Population-based deterministic models were first used to
illustrate the importance of the contact structure and
dynamic aspects of infection [11-13]. However popula-
tion-based models fail to capture important individual
level effects in the sexual network. For example, re-infec-
tion is dependent on the infection and treatment status of
current partners, not the average level of infection in the
community. Individual based models of STI transmission
with dynamic sexual partnerships have been developed
which can incorporate such effects [14,15]. Ghani et al
developed an individual-based, dynamic sexual network
model of gonorrhoea transmission within a highly active
"core-group" population [15]. Individuals and their part-
nerships are explicitly represented, enabling detailed anal-
ysis of the network structure. Partnerships form according
to mixing preferences based on sexual activity level and
dissolve dynamically.
There is a growing public health need for a realistic,
dynamic model of chlamydia transmission to inform and
interpret the potential effect of interventions such as
screening programmes and partner notification [16] To
this end it was necessary to extend Ghani's model. The dis-
tribution of chlamydia is more widespread and less
focussed in core groups than gonorrhoea, so a population
model was developed [17]. The US Add Health study
found a ten-fold higher prevalence of chlamydia (4.19%)
compared with gonorrhoea (0.43%) in a probability sam-
ple of 18–26 year olds [2]. In the UK there were 104,155
chlamydia diagnoses in GUM clinics in 2004, compared
with 22,335 of gonorrhoea [18] To be realistic, the model
also requires age-structure, because chlamydia prevalence
declines with increasing age [1], and at the population
level sexual behaviour and partner choice are strongly age-
dependent [19,20]. Therefore, we extended the model to
incorporate age-structured sexual behaviour and partner-
ship preferences in the general population. The final
model is a realistic representation of sexual behaviour and
chlamydia epidemiology in England, but is also broadly
applicable in other developed world settings.
The purpose of this paper is to describe the model param-
eterisation method and to present the values of selected
parameters that will be used in future applications to
explore chlamydia screening interventions.
Method
Model description
The model is a stochastic, individual based network
model based on that described by Ghani et al [15]. It is
exclusively heterosexual and includes dynamic partner-
ship choice, formation and dissolution, disease transmis-
sion, and recovery. The model has a Susceptible-Infected-
Susceptible (SIS) structure. Susceptible individuals are
infected, then either seek care or remain untreated, return-
ing to a susceptible state following spontaneous recovery
or treatment. The extended model also incorporates age-
structured sexual behaviour and mixing, screening, and
partner treatment. The resulting complex model can sim-
ulate a range of sexual behaviour, disease transmission
and control programmes. The model simulates sexual
behaviour, chlamydia transmission and interventions in
Britain.
The parameterisation of sexual behaviour was primarily
informed by the National Survey of Sexual Behaviour and
Lifestyles (Natsal) 2000 [19,21,22], a stratified, nationally
representative, probability sample survey of men and
women in Britain aged 16–44. Over 12,000 individuals in
the core sample, including an ethnic minority boost sam-
ple, were asked about their sexual behaviour via face-to-
face interview and computer assisted self-interview
('CASI') [23]. The response rate was 65.4% in the core
sample and 63.0% in the ethnic minority boost sample.
Sexual behaviour
Individuals are explicitly represented in the model by age,
gender, preferred number of partners, preferred duration
of partnerships, identity of current and past partners,
infection status (and whether actively seeking treatment
or not), and other clinical characteristics such as number
of screens and results. For ease of analysis, behavioural
data equivalent to Natsal 2000 [19,21,22]questionnaire
responses (including partners in the last year and new
partners in the last year) were also stored for each individ-
ual.
The rate of sexual partner change for an individual is
determined by the rate of new partnership formation, the
availability of suitable partners, the rate at which partner-
ships dissolve, and the gap between partnerships. Individ-
uals are available to form a new partnership if their
current number of partnerships is less than their desiredTheoretical Biology and Medical Modelling 2006, 3:3 http://www.tbiomed.com/content/3/1/3
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number of partnerships (either 1 or 2). Potential pairs are
selected at random from the pool of available candidates
and the partnership forms stochastically according to
probabilities assigned in age mixing matrices for men and
women (derived from Natsal 2000 data). Most partner-
ships form between people of the same age and men have
a tendency to form partnerships with women somewhat
younger than themselves (age difference mode = 0 years,
mean = 2) [19]. The duration of partnerships is assumed
to be exponentially distributed, giving a constant per
time-step probability of a partnership dissolving of 1/
(average duration of partnership). Long and short partner-
ships have different mean durations (Table 1). When a
new partnership forms in the model, one person from the
pair is selected at random and that person's preferred
duration (long or short) is assigned to the new partner-
ship. This means that those who prefer long partnerships
sometimes have short partnerships, and vice versa. There
is a gap between partnerships, during which time an indi-
vidual cannot form any new partnerships, plus an addi-
tional period of time when an individual cannot form a
partnership with their most recent partner to prevent the
same partnership reforming immediately the pair become
available.
The level of concurrency is defined as the proportion of
the population that prefer 2 partners until they reach 35
years of age, fixed at 5% in these simulations (Table 1).
After age 35, all persons prefer one sex partner [24],
although existing partnerships are not ended. If either
partner has an existing partner when the partnership
forms, the concurrent partnership is always assigned as
short.
Age dependent processes
Age is an important determinant of sexual behaviour and
chlamydia risk [19-21]. The model population is aged 16–
44, as in Natsal 2000. Aging occurs deterministically once
per year for all individuals in the population. The prefer-
ences for new partnerships (but not existing partnerships)
are adjusted annually. When an individual reaches age 45,
they are removed from the population and a new 16 year
old enters (gender maintained). Existing partnerships are
not ended, but are flagged as external to the population,
so that individuals <45 year of age in a stable partnership
do not become prematurely available for new partner-
ships when their partner passes 45 years of age.
In the model, sexual partnerships form stochastically
according to age mixing preferences. Individuals generally
form fewer new partnerships as they age. This is imple-
mented by a fraction of the population who prefer short
partnerships switching to long, all those who prefer long
partnerships increasing the average duration of partner-
Table 1: Fixed model parameters
Parameter Best fit or 
estimated 
value
Source
Behavioural parameters
Population size (Female = 20,000, Male = 20,000) 40,000 -
Age range in years (uniform distribution) 16–44 Natsal 2000 [19]
Preferred number of concurrent partners Natsal 2000 [19]
<35 years old 1 or 2
35+ years old 1
Proportion wanting 2 partners (< 35 years old) 0.05 Assumption based on Kretzschmar model [24]
Mean duration of short partnerships (days) 14 Assumption based on Natsal 2000 [19]
Number of sex acts per day Assumption based on Kretzschmar model [24]
Short partnerships 1
Long partnerships 0.25
Mean gap in days between partnerships (dispersion)* 14 (2) Assumption
Infection parameters
Duration (in days) Assumption based on Golden [10], Korenromp [30]
No treatment seeking 180
Treatment seeking 30
Mean refractory period (in days) following treatment (dispersion)* 7 (10) Assumption based on CEG guidelines [5]
Health care parameters
Attendance rate at health care setting (proportion who report attending a 
health care setting in the last 12 months)
0.85 Chlamydia Recall Study [26,27]
Treatment efficacy (in those partner notified or screened) 0.95 Treatment guidelines [37]
Mean delay (in days) before partner treatment (dispersion)* 7 (10) Assumption based on unpublished Recall study
Probability of accepting screen 0.5 Assumption based on screening studies [38,39]
*Parameters drawn from a negative binomial distribution, mean and dispersion.Theoretical Biology and Medical Modelling 2006, 3:3 http://www.tbiomed.com/content/3/1/3
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ships (i.e. decreasing the chance of the partnership dis-
solving) and shifting the preference for partners of
different ages according to the age mixing matrices.
Infection processes
Transmission of chlamydia occurs stochastically between
an infected index case and uninfected current partner,
with a per sex act probability, assuming one sex act per day
in partnerships which have lasted less than one month
and 0.25 per day in longer partnerships.
There is a constant per day probability of recovery of (1/
average duration of infection). A fraction of newly
infected individuals are assumed to actively seek treat-
ment and to recover at a faster rate than those not seeking
treatment. The recovery rate of those not seeking care is
influenced by the level of screening and partner notifica-
tion. After treatment for any reason, individuals enter a
variable refractory period during which re-infection can-
not occur, to simulate patients following advice to abstain
for a week and until partners have been treated (British
Association of Sexual Health and HIV (BASHH) guide-
lines) [5].
Partner notification and screening
Partner notification is implemented by examining part-
nerships within the last 3 months (as per BASHH guide-
lines) [5]. For each partner there is a probability of being
contacted. Notified partners are treated after a variable
delay following treatment of the index case, with certain
efficacy. Individuals may be partner notified as a result of
the index seeking treatment due to symptoms or screen-
ing. For individuals treated via partner notification, their
partners are not traced.
Various screening programmes can be implemented in the
model, some of which are explored in Turner et al (Turner
KME, Adams EJ, LaMontagne DS, Emmett L, Baster K,
Edmunds WJ. Modelling the effectiveness of chlamydia
screening in England (submitted). Available upon
request).
Model parameterisation
For many of the model parameters few data are available
(e.g. fraction of individuals who seek treatment for infec-
tions), the value is highly variable (e.g. duration of
untreated infection [10,25]) or the parameter of interest
cannot be measured directly (e.g. sexual behaviour is usu-
ally collected retrospectively and cross-sectionally as
number of partners over a given time period, but is imple-
mented prospectively as desired partner formation and
dissolution rates). Therefore, some of the parameters are
estimated by fitting the model to data.
Behavioural parameters were informed principally by
Natsal 2000 [19,21,22].Infection and treatment parame-
ters were fitted using Natsal 2000 and other available data
sources [1,21,26,27].
Frequency of age differences between sexual partners (males compared to females, aged 16–44) observed in Natsal 2000 and  in the model Figure 1
Frequency of age differences between sexual partners (males compared to females, aged 16–44) observed in Natsal 2000 and 
in the model.
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Behavioural parameter estimation
Estimation of behavioural parameters was done in two
stages: an exploratory stage, to assess the impact of differ-
ent parameters on model behaviour and to refine param-
eter ranges, followed by a second phase of fitting using
maximum likelihood. Several parameters were unknown:
• the proportion of individuals desiring short partner-
ships (males (M) and females (F))
• the proportion of individuals changing from wanting
short partnerships to long partnership each year (M, F)
• the average duration of long partnerships (M, F)
• the annual increase in preferred partnership duration
(M, F)
• the duration of the average gap between partnerships.
Sexual behaviour stabilised after running the model for 10
years, and a population of 6000 (3000 males and
females) was sufficient to generate the range of behaviour
observed in larger model populations. Latin hypercube
sampling (LHS) was used to generate more than 800
parameter sets in the exploratory phase. The average of 5
model realisations was used to maximise efficiency. There
was high correlation between the parameters in determin-
ing the fit of the model.
The model outputs were grouped by age, sex and sexual
activity and were compared to Natsal 2000 data. Sexual
activity groups were defined on the basis of number of
partners (0–1, 2–3, 4–7, 8+) and were populated with
either the number of individuals reporting that activity
level (i.e. frequency) or the number of partnerships con-
tributed by individuals within that group (weighted fre-
quency).
In the Natsal 2000 survey, there was inconsistency
between genders in reported behaviour: men reported on
average 1.5 times as many partners as women, in common
with other such surveys [19,28]. During the exploratory
phase, male and female data were therefore fitted sepa-
rately, using least squares. Fitting to the male reported
data generated higher rates of partner change than fitting
to female data. Fitting to data on the number of partner-
ships generated higher rates of partner change than fitting
to the number of individuals observed with different lev-
els of activity.
For the second phase, the model was fitted using maxi-
mum likelihood to male partnerships in the last year only.
This best replicated the variability and range of observed
Table 2: Fitted model parameters
Parameter Best fit or 
estimated value
Limits of 95% CI Range (increment) Source
Behavioural parameters
Proportion that switch from desiring short to 
long partnerships per year
Fitted to Natsal 2000 [19]
Men 0.04 0.02–0.06 0.0–0.08
Women 0.08 0.06–0.08 0.04–0.12 (0.02)
Initial proportion of 16 year olds desiring short 
partnerships
Fitted to Natsal 2000 [19]
Men 0.6 0.5–0.7 0.4–0.8
Women 0.5 0.4–0.6 0.3–0.7 (0.1)
Mean duration in days of long partnerships (16 
year olds)
900 Based on exploratory 
fitting to Natsal 2000 [19]
Increase in partnership duration per year, in days 200 Based on exploratory 
fitting to Natsal 2000 [19]
Infection parameters
Transmission probability per sex act 0.0375 0.035–0.04 0.035–0.05 (0.0025) Fitted to Natsal 2000 [19] 
& Adams et al [1]
Proportion seeking treatment Fitted to Natsal 2000 [19] 
& Adams et al [1]
Men 0.0 0.04–0.05 0–0.05
Women 0.045 0–0.005 0–0.055 (0.005)
Health care parameters
Proportion of partners notified 0.2 0.1–0.25 0.0–0.5 (0.05) Fitted to Natsal 2000 [21] 
& Adams et al [1]
Note: Fitted parameters are presented with the limits of the 95% confidence intervals (meaning that the 95% CI lies within those limits, further 
refinement was not done). The range tested in the fitting routines and the increment used is also shown.Theoretical Biology and Medical Modelling 2006, 3:3 http://www.tbiomed.com/content/3/1/3
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behaviour, giving a longer tail to the distribution (i.e.
including a few individuals with many partners). It has
also been suggested that male reporting may be more reli-
able than females [29].
Results from the exploratory runs showed that varying as
few as four population parameters was sufficient to gener-
ate a range of sexual behaviour comparable with the
empirical data. The proportion of short partnerships (M,
F) at recruitment into the sexually active population and
the proportion that change from preferring short to long
partnerships (M, F) were therefore varied in the second
phase. The remaining parameters were fixed (Table 1):
average duration of long partnerships in 16 year olds, the
annual increase in desired partnership duration, duration
of short partnerships and the duration of the gap between
partnerships. All fixed parameters were assumed to be the
same for men and women. The log likelihood, saturated
log likelihood and deviance were calculated (Appendix).
Behavioural parameters and their best fit values are given
in Table 2. A matrix of probabilities of partnership forma-
tion by age was derived from the age differences between
Proportion of partnerships contributed by different activity groups for the best fitting model (fitted to male partnerships),  model output compared with Natsal 2000 data by age group and gender Figure 2
Proportion of partnerships contributed by different activity groups for the best fitting model (fitted to male partnerships), 
model output compared with Natsal 2000 data by age group and gender.
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sexual partners observed in Natsal 2000 data and used in
the model. The age differences observed in the model are
compared with Natsal 2000 in Figure 1.
Infection parameter fitting
Chlamydia prevalence in the model depends on the trans-
mission probability, duration of infection in those cases
seeking treatment and not seeking treatment, the propor-
tion seeking treatment, and the level of partner notifica-
tion. Estimates for the duration of chlamydial infection
vary greatly [10,30]. Further, the duration and transmis-
sion probability are highly correlated in determining
chlamydia prevalence. We therefore chose to fix the aver-
age duration of infection in men and women at one
month for those seeking treatment and six months for
those not seeking treatment. The transmission probabil-
ity, the proportion seeking treatment (M/F), and the level
of partner notification were allowed to vary. Infection was
introduced into the population and run for 15 years to
reach a stable equilibrium, before calculating the model
fit.
The model was fitted to data on chlamydia prevalence in
women and the proportion of individuals who have
reported ever having been diagnosed with chlamydia (and
presumed treated), by age and gender [1,21]. Chlamydia
prevalence estimates were taken from a systematic review
of chlamydia prevalence in general practice (GP) clinic
attendees [1]. These were estimated for various factors
using a random effects regression model. Numerators and
denominators were generated to ensure the prevalence
and their 95% confidence intervals (CI) were the same as
those in the systematic review [1]. Data on previous
chlamydia diagnoses were obtained from the Natsal 2000
survey. Those older than 25 years reported less past treat-
ment for chlamydia than younger women, which may
reflect recent changes in testing, treatment, prevalence, or
recall bias. Therefore data on previous diagnosis for males
and females aged <25 years only and chlamydia preva-
lence in all age groups were used to fit the model. The
binomial log likelihood, saturated log likelihood and
deviance for each subgroup were calculated and then
summed (Appendix).
Exploratory runs of the model were performed to predict
the likely range of values for the varied parameters (each
parameter set was averaged over 15 simulations). This
Baseline model chlamydia prevalence by age compared with  estimated prevalence in general practice attendees (Adams et  al, 2004) [1] Figure 4
Baseline model chlamydia prevalence by age compared with 
estimated prevalence in general practice attendees (Adams et 
al, 2004) [1].
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range was then further refined by systematically combin-
ing parameters (proportion seeking treatment (M/F),
transmission probability, and partner notification), by
fixing two parameters and allowing the others to vary.
Once a local best fit was found (lowest deviance), the
other parameters were varied to search for a better fit.
Thirty realisations were performed for each parameter set
for the final fitting routines. Univariate sensitivity analysis
was performed for each of the five parameters, and the
95% CI was estimated by finding those parameter values
that lie within 3.84 of the deviance estimate.
Results
The results of fitting the model to behavioural data are
shown in Figure 2 for male and female partnerships in the
last year. The best fit parameter values, and the values that
gave fits within 95% confidence limits are presented in
Table 2. The model fits better to the male data than the
female data, due to the choice of fitting procedure (i.e.,
the model was fitted to male behavioural data). In both
males and females, the model overestimates the number
of partners of the youngest age groups, and slightly under-
estimates in older age groups. The fitted model has a
higher rate of partner change in females than observed in
the data. The discrepancy between data and model is
greatest in the youngest women
Given the set of behavioural parameters, the estimated
biological parameters (and 95% confidence intervals)
that produced the best fit are shown in Table 2. The best
fitting model suggests a partner notification efficacy of
20%, per sex act transmission probability of 0.0375 and
that a small fraction of cases are treated as a result of active
treatment seeking (less than 5% of new female and 0.05%
of new male cases). The best fitting model results are
shown in comparison with the proportion reporting
chlamydia treatment (Figure 3) and the prevalence of
chlamydia in women (Figure 4).
Discussion
The aim of this study was to develop a flexible, credible
model of chlamydia transmission in Britain to address
public health questions regarding chlamydia epidemiol-
ogy and interventions including screening. We extended
the model of Ghani et al to incorporate relevant features
such as age-dependent sexual behaviour [15]. We used
multiple data sources and an iterative process of parame-
ter fitting and refinement to estimate sexual behaviour
and biological parameters representative of current
chlamydia epidemiology in Britain.
The distribution of sexual behaviour in the fitted model is
broadly similar to that observed in Britain (Figure 2). In
the model the total number of partnerships contributed
by men and women are equal, because it is a closed pop-
ulation and partnerships can be counted perfectly. How-
ever, the model was fitted to male partnership data from
Natsal 2000, which found that men report more partner-
ships than women [19,28]. Data available to validate and
parameterise the model are based on retrospective
accounts of individual's sexual behaviour, which are sub-
ject to various biases [31,32]. The reasons for the observed
discrepancy are not fully understood, but could include
male over-reporting, female under-reporting or gender
differences in the distribution of partners. An Australian
study compared reports of sexual behaviour under differ-
ent survey conditions and found that males' reports were
more consistent than females', and that females tended to
report fewer partners when they believed the responses
were not anonymous compared with when they believed
lies would be detected, suggesting a bias towards underre-
porting [29]. Others have suggested that the difference
between men and women primarily lies in the tail of the
distribution and that female sex workers, who are likely to
be poorly represented in population-based surveys, may
supply the extra partnerships reported by men [33,34].
The true situation is probably a combination of these. We
chose to fit the model to behaviour reported by men, as
this may be more reliable. However, the sexual activity of
women in the model is then higher than that reported in
the data. The difference is greatest in the youngest women.
If we had fitted to either women or some average of both,
the model would have fitted neither data set well,
although the overall model behaviour would be roughly
similar and the fitted infection parameters would be
slightly different.
The distribution of chlamydia by age and the number of
people treated for infection follows that observed in
young women [1,21]. Chlamydia prevalence is highest in
the youngest age groups and lowest in the oldest. While
surveillance data from genitourinary medicine clinics sug-
gest that male prevalence may be highest in the 20–24
year old ages [18], a recent review does not suggest a dif-
ference in male and female prevalence, therefore we fitted
to female data only. More data on the prevalence and inci-
dence of chlamydia in men are needed to improve the
parameter estimates [1].
The estimates of transmission probability are highly
dependent on the values of the duration of infection cho-
sen, but there are few reliable data on the timing of treat-
ment or recovery under different scenarios of symptoms,
contact tracing and screening. If the average duration of all
infections were shorter than we modelled, the transmis-
sion probability would need to be higher to fit to the same
overall prevalence. The level of partner notification (that
is partners of contacts are known to have been tested and
treated) predicted by the best fitting model was 20%. Data
from the Chlamydia Recall Study suggested that partnerTheoretical Biology and Medical Modelling 2006, 3:3 http://www.tbiomed.com/content/3/1/3
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notification might be as high as 50% in a study setting
[26]. There are problems in interpreting the estimate of
20% as it is also correlated with the other infection param-
eter estimates and was fitted to the observed low rate of
treatment. However the efficacy in a non-study setting is
likely to be lower and the importance of maintaining and
improving partner notification is crucial to the long-term
success and effectiveness of interventions.
The proportion seeking treatment is low compared with
other estimates of the proportion symptomatic [3,24,35].
This is due to several reasons. Firstly, active treatment
seeking is not directly analogous to symptomaticity,
which is an assumption in our model. A modelling study
has suggested that the proportion of time an infection
shows symptoms may be less frequent and also intermit-
tent [30], and therefore may not prompt an individual to
seek treatment if his/her symptoms disappear. In a recent
US Add Health study, 4.19% of 18–26 year olds were
infected with chlamydia, and more than 95% of infec-
tions were asymptomatic [2]. In the model, those who
have reported treatment for chlamydia may have done so
from either seeking treatment or through partner notifica-
tion. In reality, treatment may be more frequent (with or
without confirmed diagnosis) due to co-treatment of gon-
orrhoea cases or syndromic management of urethritis in
men [36]. Secondly, we fitted to very low rates of treat-
ment observed in the population, particularly among
men, based on retrospective data collected by Natsal
2000. Recent data from the Health Protection Agency
show that chlamydia diagnoses (and presumably treat-
ment) have increased since 2000, from both a real
increase in chlamydia prevalence and increased testing
and diagnoses through education and screening [18]. We
compared our estimates of treatment seeking to those in
the model by Kretzschmar et al [24], which is the most
thorough study published to date and is broadly compa-
rable to ours in terms of structure and dynamics. We ran
our model using the infection parameters from their pub-
lished model, including a higher proportion of sympto-
matic infection (higher treatment rate). The model
chlamydia prevalence was similar to that observed using
our values, but the proportion of 20–24 year olds ever
treated was over 45%. This compares with 4.5% in the fit-
ted model and 5.1% (3.7–6.9%, 95% CI) of 20–24 year
old women ever treated for chlamydia reported in Natsal
2000. Similarly, the Chlamydia Recall Study found that
8% of women aged 20–24 reported past treatment for
chlamydia [26]. We believe that, although the true rate of
treatment seeking maybe higher than we estimated, the
novel use of data on reported rates of treatment to param-
eterise the model has led to a more credible model and is
justified by the fit to data.
The model is complex and there are many interactions
between the parameters. Therefore the values presented
here should be considered as a best fitting set of parame-
ters, rather than taken individually. There are limitations
to the model structure, e.g. there may be more individual
variability between individuals during their sexual life his-
tories than we were able to simulate. There is a trade-off
between model complexity and the ability to validate the
model with data. More data are needed on sexual life his-
tories as well as further analysis of the sensitivity and
robustness of the model assumptions. The advantages of
this individual based model over other possible choices
are that the history of individuals can be tracked over
time, e.g. exposure to infection, previous partners or
number of screens. Infection and reinfection events occur
within explicitly defined partnerships, which enables
partner notification. Finally the model structure is very
flexible and additional screening or partner notification
strategies and other behavioural patterns or infections can
be added.
Conclusion
The model is applicable to other developed world set-
tings. It is being used to investigate the effectiveness of
interventions such as chlamydia screening in England
(Turner et al, submitted). Modelling is underway to
improve understanding of the natural history of pelvic
inflammatory disease and estimate the cost-effectiveness
of interventions designed to prevent it. The model fitting
was as systematic as possible given the limitations of com-
puting time and data. A strength is the use of novel data
on past treatment to improve parameter estimates. We
therefore believe this model to be a significant improve-
ment in providing a realistic model for use in public
health decision-making.
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Appendix
The proportion of males in each sexual activity group
(defined by the number of partnerships in the last year) by
age group is assumed to follow a multinomial distribu-Theoretical Biology and Medical Modelling 2006, 3:3 http://www.tbiomed.com/content/3/1/3
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tion. The log-likelihood (Lbeh) of the model given the data
and the saturated log-likelihood (Lbeh*) are given by:
where Qap is the number of males (female results not used
for final fitting), age group a (16–19, 20–24, 25–29, 30–
34, 35–39, 40–44) and sexual activity group p with a given
number of partners (1, 2–3, 4–7, 8+) observed from Nat-
sal, and yap and zap are the proportion of males, age group
a with p number of partners, from the Natsal 2000 data
and observed in the model, respectively. The deviance is
given by:
Devbeh = (- 2*(Lap - Lap*))
which was minimised to find the best fitting set of behav-
ioural parameters.
The biological parameters were also fitted using maxi-
mum likelihood. As the data are binomial the model log
likelihood (Lbio) and saturated log likelihood (Lbio *) are
given by:
Lbio = Lbio_prev + Lbio_prop
Lbio* = Lbio_prev* + Lbio_prop*
The formula is illustrated for Lbio_prev, and is the same for
Lbio_prop:
where  Iga  is the observed number of infected, Sga  the
observed number of susceptibles, and xga is the model esti-
mate of the proportion of infected, by gender g and age
group a. For prevalence, g (females), by four age groups a
(16–19, 20–24, 25–29, 30–44) and for the proportion
ever treated, g (males, females) by two age groups (16–19,
20–24) and the values summed.
The deviance was calculated and minimised in the fitting
routine:
Devbeh = (- 2*(Lap - Lap*)).
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